AFP and hepatocellular carcinoma: In 1997, Tsai et al. reported that an AUROC of 0.730 distinguishes HCC from liver cirrhosis, with a sensitivity of 53.1% and a specificity of 98.9%; when combined with serum AFP, the sensitivity increased to 84.0% and the specificity to 97.8% [17].